New agents for DOAC reversal: a practical management review

Area of Science:

• Pharmacology and Toxicology
• Internal Medicine
• Cardiology

Background:

• Anticoagulant therapy is essential for preventing thrombotic events but carries a risk of bleeding.
• Bleeding is a significant adverse event associated with anticoagulant use, necessitating effective management strategies.
• Severe or life-threatening bleeding requires prompt intervention with specific reversal agents.

Purpose of the Study:

• To provide comprehensive guidance on the use of direct oral anticoagulant (DOAC) reversal agents.
• To detail the indications, appropriate dosing, and potential side effects of DOAC antidotes.
• To support clinicians in managing bleeding complications associated with DOACs.

Main Methods:

• Literature review focusing on direct oral anticoagulant (DOAC) reversal agents.
• Analysis of clinical guidelines and pharmacological data regarding DOAC antidotes.
• Synthesis of information on indications, dosing regimens, and adverse events.

Main Results:

• Specific antidotes are available for reversing the effects of direct oral anticoagulants (DOACs).
• Clear indications and recommended dosing strategies exist for the effective use of DOAC reversal agents.
• Understanding potential side effects is crucial for safe administration of these antidotes.

Conclusions:

• Direct oral anticoagulant (DOAC) reversal agents are critical for managing severe bleeding.
• This review offers essential guidance on the appropriate application of DOAC antidotes.
• Safe and effective use of DOACs relies on knowledge of their reversal agents and potential complications.